OtherCellular and Molecular
Conversion of phosphodiesterase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors
Mitsi A. Blount, Roya Zoraghi, Emmanuel P. Bessay, Alfreda Beasley, Sharron H. Francis and Jackie D. Corbin
Journal of Pharmacology and Experimental Therapeutics August 9, 2007, DOI: https://doi.org/10.1124/jpet.107.126540
Mitsi A. Blount
Roya Zoraghi
Emmanuel P. Bessay
Alfreda Beasley
Sharron H. Francis
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherCellular and Molecular
Conversion of phosphodiesterase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors
Mitsi A. Blount, Roya Zoraghi, Emmanuel P. Bessay, Alfreda Beasley, Sharron H. Francis and Jackie D. Corbin
Journal of Pharmacology and Experimental Therapeutics August 9, 2007, DOI: https://doi.org/10.1124/jpet.107.126540
OtherCellular and Molecular
Conversion of phosphodiesterase-5 (PDE5) catalytic site to higher affinity by PDE5 inhibitors
Mitsi A. Blount, Roya Zoraghi, Emmanuel P. Bessay, Alfreda Beasley, Sharron H. Francis and Jackie D. Corbin
Journal of Pharmacology and Experimental Therapeutics August 9, 2007, DOI: https://doi.org/10.1124/jpet.107.126540
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement